Multichannel vaginal cylinder brachytherapy—Impact of tumor thickness and location on dose to organs at risk
Authors:
- 1 November 2015
- journal article
- Published by Elsevier in Brachytherapy
- Vol. 14 (6) , 913-918
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Patterns of care and brachytherapy boost utilization for vaginal cancer in the United StatesPractical Radiation Oncology, 2015
- Definitive salvage for vaginal recurrence of endometrial cancer: The impact of modern intensity-modulated-radiotherapy with image-based HDR brachytherapy and the interplay of the PORTEC 1 risk stratificationRadiotherapy and Oncology, 2014
- Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trialThe Lancet, 2010
- High-dose rate brachytherapy (HDRB) for primary or recurrent cancer in the vaginaRadiation Oncology, 2008
- Salvage of isolated vaginal recurrences in women with surgical stage I endometrial cancer: a multiinstitutional experienceInternational Journal of Gynecological Cancer, 2007
- High-dose-rate interstitial brachytherapy for gynecologic malignanciesBrachytherapy, 2006
- Salvage treatment with high-dose-rate brachytherapy for isolated vaginal endometrial cancer recurrenceGynecologic Oncology, 2006
- Definitive radiotherapy for patients with isolated vaginal recurrence of endometrial carcinoma after hysterectomyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2003
- High-dose-rate (HDR) brachytherapy with or without external beam radiotherapy in the treatment of primary vaginal carcinoma: Long-term results and side effectsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2003
- Interstitial brachytherapy for salvage treatment of vaginal recurrences in previously unirradiated endometrial cancer patientsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2002